Loading company…
Syndexa Pharmaceuticals develops therapies to address unmet medical needs.
Formed in 2005 and based in Watertown, US, Syndexa Pharmaceuticals operates in pharmaceutical development. The company has completed four funding deals, including a Series B round that raised USD 15.00 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in